SBRT Has Excellent Outcomes for Intermediate Risk PCa Patients

Stereotactic body radiation therapy or SBRT (sometimes referred to as Cyberknife or SHARP) has had excellent 7-year outcomes in an update of the consortium study, including data from 10 single-institution trials and two multi-institutional trials.  Get the details HERE.